Market Overview

D.A. Davidson Reiterates Buy Rating on Herbalife Ltd. as Short-Covering Begins

Related HLF
Dietary Supplement Stocks Getting Killed By DoJ, FDA's Forthcoming Press Conference
Keep an Eye on These 10 Stocks for November 4, 2015

In a report published Friday, D.A. Davidson analyst Timothy S. Ramey reiterated a Buy rating and $78.00 price target on Herbalife (NYSE: HLF).

In the report, D.A. Davidson noted, “Herbalife's short interest, which peaked at 37.2 million shares on December 31st (at a price of $32.94), fell recently to a still-huge 31 million shares on May 31st, down from 33 million shares on May 15th. The shorts have been buried in this position since the start of the year, with the stock up $12.50 plus $0.60 in dividends for a total return, year-to-date of 40%. That is before the 2.75% cost to borrow the stock. The short thesis has been thoroughly discredited and even on a day such as today, when a congresswoman asks the FTC to investigate Herbalife as a pyramid scheme, the shares are up.”

Herbalife closed on Thursday at $46.86.

Latest Ratings for HLF

Aug 2015Pivotal ResearchMaintainsBuy
May 2015Canaccord GenuityMaintainsBuy
Mar 2015Canaccord GenuityMaintainsBuy

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: D.A. Davidson Timothy S. RameyAnalyst Color Reiteration Analyst Ratings


Related Articles (HLF)

View Comments and Join the Discussion!

Get Benzinga's Newsletters